• Sarepta Therapeutics average return on equity for 2023 was -133.41, a 59.56% decline from 2022.
• Sarepta Therapeutics average return on equity for 2022 was -83.61, a 0.76% increase from 2021.
• Sarepta Therapeutics average return on equity for 2021 was -84.25, a 42.36% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.